The Top Gift: Caring

It's darker and colder than usual these days - a crummy time to realize you or a loved one has cancer. With lymphoma, this is usually a temporary thing as remission may come soon but that comfort might be hard to muster.



The best gift in these days may be the caring of those around. A hot dish or plate of cookies may be welcome. The offer for a ride & back to treatment, the comfort of a phone call or visit, the offer to take the kids to a movie might be great. Anything personal or helpful would most likely be very appreciated as even the simplest of tasks can be gigantic to the cancer sufferer.



If someone finds it hard to talk to the patient, you should realize that just gereral chat, at ease, would be welcome. Remember gabbing on the phone before the diagnosis, try that again as it is usually ok. Lend an ear to someone if they need it.



The great thing is these acts of kindness cost very little but mean alot.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap